These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19784481)

  • 21. Sequential monitoring of leprosy patients with serum antibody levels to phenolic glycolipid-I, a synthetic analog of phenolic glycolipid-I, and mycobacterial lipoarabinomannan.
    Meeker HC; Schuller-Levis G; Fusco F; Giardina-Becket MA; Sersen E; Levis WR
    Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):503-11. PubMed ID: 2205685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of recombinant serine-rich 45-kDa antigen (ML0411) for detection of antibodies in leprosy patients.
    Parkash O; Kumar A; Nigam A; Franken KL; Ottenhoff TH
    Scand J Immunol; 2006 Oct; 64(4):450-5. PubMed ID: 16970689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody response to recombinant 65-kDa, 70-kDa and 18-kDa mycobacterial antigens in leprosy patients and healthy contacts in a leprosy-endemic population.
    Ilangumaran S; Shankernarayan N; Ramu G; Muthukkaruppan V
    Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):245-55. PubMed ID: 7519226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA-PCR and RT-PCR for the 18-kDa gene of Mycobacterium leprae to assess the efficacy of multi-drug therapy for leprosy.
    Chae GT; Kim MJ; Kang TJ; Lee SB; Shin HK; Kim JP; Ko YH; Kim SH; Kim NH
    J Med Microbiol; 2002 May; 51(5):417-422. PubMed ID: 11990494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term evaluation of immune status in leprosy patients undergoing multiple drug therapy.
    Vu TT; Hoang TL; Nguyen DQ; Ho ML; Nguyen DH; Le TH; Dang DT; Nguyen QA; Le TP; Tran HK
    Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):365-73. PubMed ID: 7963908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific anti-M leprae PGL-I antibodies and Mitsuda reaction in the management of household contacts in New Caledonia.
    Desforges S; Bobin P; Brethes B; Huerre M; Moreau JP; Bach MA
    Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):794-800. PubMed ID: 2681462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of a different buffer system in the phenolic glycolipid-I ELISA.
    Sticht-Groh V; Alvarenga AE; Vettom L; von Ballestrem W
    Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):570-4. PubMed ID: 1299712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody response to phenolic glycolipid I and Mycobacterium w antigens and its relation to bacterial load in M. leprae-infected mice and leprosy patients.
    Moudgil KD; Gupta SK; Naraynan PR; Srivastava LM; Mishra RS; Talwar GP
    Clin Exp Immunol; 1989 Nov; 78(2):214-8. PubMed ID: 12412751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-PGL-I seroepidemiology in leprosy cases: household contacts and school children from a hyperendemic municipality of the Brazilian Amazon.
    Barreto JG; Guimarães Lde S; Leão MR; Ferreira DV; Lima RA; Salgado CG
    Lepr Rev; 2011 Dec; 82(4):358-70. PubMed ID: 22439276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal assessment of anti-PGL-I serology in contacts of leprosy patients in Bangladesh.
    Richardus RA; van der Zwet K; van Hooij A; Wilson L; Oskam L; Faber R; van den Eeden SJF; Pahan D; Alam K; Richardus JH; Geluk A
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006083. PubMed ID: 29228004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of phenolic glycolipid-I antigen and antibody in sera from new and relapsed lepromatous patients treated with various drug regimens.
    Cho SN; Cellona RV; Fajardo TT; Abalos RM; dela Cruz EC; Walsh GP; Kim JD; Brennan PJ
    Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):25-31. PubMed ID: 2030314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can anti-PGL-1 and anti-NDO-LID-1 antibody titers be used to predict the risk of reactions in leprosy patients?
    Devides AC; Rosa PS; de Faria Fernandes Belone A; Coelho NMB; Ura S; Silva EA
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):260-265. PubMed ID: 29669693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serologic responses to Mycobacterium leprae-specific phenolic glycolipid-I antigen in sooty mangabey monkeys with experimental leprosy.
    Gormus BJ; Ohashi DK; Ohkawa S; Walsh GP; Meyers WM; Brennan PJ; Trygg C
    Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):537-45. PubMed ID: 2464657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Armadillo IgG and IgM antibody responses to phenolic glycolipid-I during experimental infection with M. leprae.
    Vadiee AR; Shannon EJ; Gillis TP; Mshana RN; Hastings RC
    Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):422-7. PubMed ID: 3047283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serological monitoring of the response to chemotherapy in leprosy patients.
    Roche PW; Britton WJ; Failbus SS; Neupane KD; Theuvenet WJ
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):35-43. PubMed ID: 8326179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy.
    Ulrich M; Smith PG; Sampson C; Zuniga M; Centeno M; Garcia V; Manrique X; Salgado A; Convit J
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):405-15. PubMed ID: 1890364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-PGL1 salivary IgA/IgM, serum IgG/IgM, and nasal Mycobacterium leprae DNA in individuals with household contact with leprosy.
    Brito e Cabral P; Júnior JE; de Macedo AC; Alves AR; Gonçalves TB; Brito e Cabral TC; Gondim AP; Pinto MI; Oseki KT; Camara LM; Rabenhorst SH; Nagao-Dias AT
    Int J Infect Dis; 2013 Nov; 17(11):e1005-10. PubMed ID: 23871279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-Lipoarabinomannan-Specific Salivary IgA as Prognostic Marker for Leprosy Reactions in Patients and Cellular Immunity in Contacts.
    Nahas AA; Lima MIS; Goulart IMB; Goulart LR
    Front Immunol; 2018; 9():1205. PubMed ID: 29904387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody responses to the 18-kDa protein of Mycobacterium leprae in leprosy and tuberculosis patients.
    Roche PW; Prestidge RL; Watson JD; Britton WJ
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):201-7. PubMed ID: 1381739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leprosy reactions: The predictive value of Mycobacterium leprae-specific serology evaluated in a Brazilian cohort of leprosy patients (U-MDT/CT-BR).
    Hungria EM; Bührer-Sékula S; de Oliveira RM; Aderaldo LC; Pontes AA; Cruz R; Gonçalves HS; Penna ML; Penna GO; Stefani MM
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005396. PubMed ID: 28222139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.